Rein Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Rein Therapeutics, Inc. (RNTX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $0 as of 2022-12-31, per its 10-K filed 2024-04-15.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2024-04-15
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $0.00; Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed $2.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $14.00K.
- 2019-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.39M.
- 2019-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.54M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed |
|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2024-04-15 | $2.00K 10-K · filed 2023-03-20 |
| 2021-12-31 | $14.00K 10-K · filed 2022-03-28 | |
| 2019-12-31 | $2.39M 10-K · filed 2020-03-30 | |
| 2019-09-30 | $2.54M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.70M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $2.85M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |